Anti-Ro(SSA)/JJ
autoantibodies/NNS
are/VBP
associated/VBN
with/IN
T/NN
cell/NN
receptor/NN
beta/NN
genes/NNS
in/IN
systemic/JJ
lupus/NN
erythematosus/NN
patients/NNS
./.

Several/JJ
of/IN
the/DT
heterogeneous/JJ
clinical/JJ
manifestations/NNS
of/IN
systemic/JJ
lupus/NN
erythematosus/NN
have/VBP
been/VBN
associated/VBN
with/IN
specific/JJ
autoantibodies/NNS
./.
=====
Associations/NNS
between/IN
HLA/NN
class/NN
II/CD
antigens/NNS
and/CC
autoantibodies/NNS
to/TO
the/DT
ribonucleoproteins/NNS
Ro(SSA)/NN
and/CC
La(SSB)/NN
have/VBP
been/VBN
reported/VBN
in/IN
these/DT
patients/NNS
./.
=====
Because/IN
HLA/NN
class/NN
II/CD
molecules/NNS
present/VBP
antigen/NN
to/TO
T/NN
cell/NN
receptors/NNS
(/(
TCRs/NNS
)/)
,/,
we/PRP
have/VBP
searched/VBN
for/IN
a/DT
TCR/NN
gene/NN
associated/VBN
with/IN
the/DT
production/NN
of/IN
anti-Ro(SSA)/JJ
antibodies/NNS
./.
=====
A/DT
pair/NN
of/IN
restriction/NN
fragment/NN
length/NN
polymorphisms/NNS
(/(
RFLPs/NNS
)/)
,/,
one/CD
of/IN
which/WDT
hybridizes/VBZ
to/TO
the/DT
TCR/NN
constant/JJ
region/NN
C/NN
beta/NN
1/CD
and/CC
the/DT
other/JJ
to/TO
the/DT
C/NN
beta/NN
2/CD
gene/NN
,/,
has/VBZ
been/VBN
identified/VBN
,/,
suggesting/VBG
these/DT
may/MD
be/VB
genotypic/JJ
markers/NNS
for/IN
an/DT
extended/VBN
region/NN
of/IN
the/DT
TCR/NN
beta/NN
locus/NN
./.
=====
This/DT
RFLP/NN
pair/NN
occurs/VBZ
in/IN
76/CD
%/NN
of/IN
patients/NNS
with/IN
Ro(SSA)/NN
precipitins/NNS
,/,
84/CD
%/NN
of/IN
anti-Ro(SSA)-positive/JJ
patients/NNS
lacking/VBG
La(SSB)/NN
precipitins/NNS
,/,
but/CC
only/RB
41/CD
%/NN
of/IN
the/DT
patients/NNS
lacking/VBG
both/DT
precipitins/NNS
(/(
P/NN
=/JJ
0.0004/CD
)/)
./.
=====
This/DT
disproportionate/JJ
occurrence/NN
in/IN
a/DT
subset/NN
of/IN
lupus/NN
patients/NNS
indicates/VBZ
that/IN
these/DT
RFLPs/NNS
are/VBP
not/RB
disease/NN
susceptibility/NN
markers/NNS
,/,
but/CC
rather/RB
are/VBP
important/JJ
markers/NNS
for/IN
TCR/NN
genes/NNS
whose/WP$
products/NNS
are/VBP
involved/VBN
in/IN
the/DT
production/NN
of/IN
anti-Ro(SSA)/JJ
antibodies/NNS
./.
=====
The/DT
majority/NN
of/IN
patients/NNS
who/WP
have/VBP
these/DT
RFLPs/NNS
and/CC
HLA/NN
class/NN
II/CD
antigens/NNS
previously/RB
associated/VBN
with/IN
the/DT
anti-Ro(SSA)/JJ
response/NN
make/VBP
this/DT
antibody/NN
,/,
suggesting/VBG
that/IN
interactions/NNS
between/IN
products/NNS
of/IN
these/DT
loci/NNS
occur/VBP
in/IN
response/NN
to/TO
Ro(SSA)/NN
./.